In a rat ischemic stroke model, LTX4 was observed to ameliorate the course of stroke by inhibiting the matrix metallopeptidase 9 (MMP-9) pathway, dependent on nuclear factor kappa B (NF-κB) and regulating oxidative stress [26,28]. The gene discussed is MMP9; the disease is stroke disorder.